CV Sciences, Inc. (CVSI) financial statements (2021 and earlier)

Company profile

Business Address 10070 BARNES CANYON ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49132112
Cash and cash equivalents49132112
Receivables1232012
Inventory, net of allowances, customer advances and progress billings9107331412
Inventory9107331412
Prepaid expense21121101
Other current assets   0   
Other undisclosed current assets11000 1
Total current assets:173225851717
Noncurrent Assets
Inventory, Noncurrent  166  
Operating lease, right-of-use asset39
Property, plant and equipment3432001
Long-term investments and receivables    0 0
Accounts and financing receivable, after allowance for credit loss    0 0
Intangible assets, net (including goodwill)77777104
Goodwill3333352
Intangible assets, net (excluding goodwill)4444463
Other noncurrent assets11     
Deferred tax assets, net    2
Other undisclosed noncurrent assets  10  (2)
Total noncurrent assets:1420111514115
TOTAL ASSETS:31533723192722
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111243111
Accounts payable2211111
Accrued liabilities101132010
Employee-related liabilities      0
Debt210121 
Derivative instruments and hedges, liabilities    0  
Business combination, contingent consideration, liability     0 
Other undisclosed current liabilities1     (0)
Total current liabilities:141343321
Noncurrent Liabilities
Long-term debt and lease obligation310 11  
Long-term debt, excluding current maturities   11  
Operating lease, liability310
Liabilities, other than long-term debt211222 
Deferred revenue and credits1   
Deferred revenue1 
Contract with customer, liability1
Deferred tax liabilities, net 122 
Deferred income tax liabilities00
Other liabilities 0     
Other undisclosed noncurrent liabilities  1    
Total noncurrent liabilities:5102322 
Total liabilities:192476541
Stockholders' equity
Stockholders' equity attributable to parent11293016132321
Common stock0000000
Additional paid in capital75715551433925
Accumulated deficit(64)(42)(25)(35)(30)(16)(4)
Total stockholders' equity:11293016132321
TOTAL LIABILITIES AND EQUITY:31533723192722

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues24544821111210
Revenue, net0 55
Financial services revenue   8
Cost of revenue(13)(19)(14)(6)(4)(4)(4)
Cost of goods and services sold (0) (1)(4)(0)(0)
Gross profit:11353414776
Operating expenses(34)(52)(24)(19)(14)(19)(14)
Other operating expense, net
(Other Expenses)
      (0)
Other undisclosed operating income (loss)    (6)10
Operating income (loss):(23)(17)10(5)(13)(11)(9)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
  (0)(1)(1)(1)7
Interest and debt expense  (0)(0)(1)(1)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(23)(17)10(6)(15)(13)(2)
Loss from equity method investments      (0)
Other undisclosed income (loss) from continuing operations before income taxes(0)0001  
Income (loss) from continuing operations before income taxes:(23)(17)10(5)(14)(13)(2)
Income tax expense (benefit)01(0)0   
Income (loss) before gain (loss) on sale of properties:(22)(17)10(5)(14)(13)(2)
Other undisclosed net income     11
Net income (loss) available to common stockholders, diluted:(22)(17)10(5)(14)(12)(1)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(22)(17)10(5)(14)(12)(1)
Comprehensive income (loss), net of tax, attributable to parent:(22)(17)10(5)(14)(12)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: